YR
Yasmeen Rahimi Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
17
Avg Return
Past Year
Past Year
38%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
85.7%
Neutral
14.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $540 |
23%
upside
| 1 | +0.41% |
0
%
| 15 Oct ‘25 4 days ago |
|
|
|
Overweight
Initiated
| $78 |
400%
upside
| 1 | +3.7% |
0
%
| 6 Oct ‘25 13 days ago |
|
|
|
Neutral
Downgraded
| $48 |
0%
upside
| 1 | – |
–
| 11 Sep ‘25 1 month ago |
|
|
|
Overweight
Initiated
| $20 |
199%
upside
| 1 | +11% |
0
%
| 8 Sep ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $15 |
51%
upside
| 1 | -3% |
0
%
| 28 Aug ‘25 1 month ago |
|
|
|
Overweight
Initiated
| $26 |
436%
upside
| 1 | +5.7% |
0
%
| 27 Aug ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $4 |
155%
upside
| 1 | -6.5% |
0
%
| 8 Aug ‘25 2 months ago |
|